Loading
SH
No insider purchase over the last 90 days. The latest, by 韩本毅, was filed 02 Mar 2026.
Shanghai Hile Bio-Technology Co., Ltd.: what insiders have been doing
Shanghai Hile Bio-Technology Co., Ltd. has a thin disclosure history in our data (latest filing: 2 March 2026). New filings will appear here as soon as they are published. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€201,363
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySale韩本毅1 buy
Since the insiders bought
- -26.6%Entry CN¥4.69 · Close at T+90 CN¥3.44
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 15,579 of 23,476 companies
41.0
score / 100
Value32
Quality50
FCF yld2.3%
Earn yld-16%
EV/EBITDA·
ROE-23%
Gross mgn72%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥3.09
Analyst consensus
Income statement
RevenueCN¥187.9M
Gross profitCN¥135.6M72% margin
EBITDA-CN¥165.7M-88% margin
Net income-CN¥311.4M-148.7% margin
Valuation
P/Book2.3x
Beta0.22
Balance sheet & cash
Market capCN¥2B
Total debtCN¥16.6M
Free Cash FlowCN¥46.7M
Debt / Equity11%
Profitability & ownership
ROE-22.6%
ROA1.3%
% insiders42.8%
% institutions0.0%
Last declaration on 2 March 2026
About Shanghai Hile Bio-Technology Co., Ltd.
*ST海利 is a company listed on the XSHG market, specializing in the chemical and materials sector. It focuses on the production and sale of various chemical products.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
